COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM

Perez Nicholas, O, Lamorde, M, Kintu, K, Wang, D, Chen, T, Malaba, T, Myer, L, Waitt, C, Reynolds, H ORCID: 0000-0001-7443-4520 and Khoo, S (2020) COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM. .

Text D2-ISPOR Abstract 2020 - USAv4_FINAL.docx - Author Accepted Manuscript Download (14kB)